Document Detail

Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma.
MedLine Citation:
PMID:  17569795     Owner:  NLM     Status:  MEDLINE    
Considering the role of aberrant beta-catenin signaling in tumorigenesis, we investigated the mechanism by which the peroxisome proliferator-activated receptor gamma (PPARgamma) agonist troglitazone facilitated beta-catenin down-regulation. We demonstrate that troglitazone and its more potent PPARgamma-inactive analogs Delta2TG and STG28 mediated the proteasomal degradation of beta-catenin in prostate cancer cells by up-regulating the expression of beta-transducin repeat-containing protein (beta-TrCP), an F-box component of the Skp1-Cul1-F-box protein E3 ubiquitin ligase. Evidence indicates that although small interfering RNA-mediated beta-TrCP knockdown protected cells against STG28-facilitated beta-catenin ablation, ectopic beta-TrCP expression enhanced the degradation. The involvement of beta-TrCP in beta-catenin degradation was also corroborated by the pull-down analysis and the concurrent down-regulation of known beta-TrCP substrates examined, including Wee1, Ikappabetaalpha, cdc25A, and nuclear factor-kappaB/p105. Furthermore, glycogen synthase kinase-3beta represented a key regulator in the effect of these thiazolidinedione derivatives on beta-catenin proteolysis even though these agents increased its phosphorylation level. It is noteworthy that this drug-induced beta-TrCP up-regulation was accompanied by the concomitant down-regulation of Skp2 and Fbw7, thereby affecting many of the target proteins of these two F-box proteins (such as p27 and cyclin E). As a consequence, the ability of troglitazone to target these F-box proteins provides a molecular basis to account for its reported effect on modulating the expression of aforementioned cell-cycle regulatory proteins. Despite this complicated mode of pharmacological actions, normal prostate epithelial cells, relative to LNCaP cells, were less susceptible to the effects of STG28 on modulating the expression of beta-catenin and beta-TrCP, suggesting the translation potential of using STG28 as a scaffold to develop more potent chemopreventive agents.
Shuo Wei; Li-Fang Lin; Chih-Cheng Yang; Yu-Chieh Wang; Geen-Dong Chang; Hungwen Chen; Ching-Shih Chen
Related Documents :
17724465 - Deregulated wnt/beta-catenin program in high-risk neuroblastomas without mycn amplifica...
17643305 - Modulation of the microtubule cytoskeleton: a role for a divergent canonical wnt pathway.
8245965 - Alterations in actin-binding beta-thymosin expression accompany neuronal differentiatio...
11345525 - A possible role for the wnt-1 pathway in oral carcinogenesis.
15576635 - Prostaglandin e synthases in zebrafish.
7547465 - Expression of zebrafish gata 3 (gta3) during gastrulation and neurulation suggests a ro...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.     Date:  2007-06-14
Journal Detail:
Title:  Molecular pharmacology     Volume:  72     ISSN:  0026-895X     ISO Abbreviation:  Mol. Pharmacol.     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-08-24     Completed Date:  2007-10-19     Revised Date:  2007-12-03    
Medline Journal Info:
Nlm Unique ID:  0035623     Medline TA:  Mol Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  725-33     Citation Subset:  IM    
Division of Medicinal Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cell Cycle Proteins / genetics,  metabolism*
Cell Line, Tumor
Cell Survival / drug effects
Cullin Proteins / genetics,  metabolism*
F-Box Proteins / genetics,  metabolism*
Formazans / metabolism
Glutathione Transferase / metabolism
PPAR gamma / metabolism*
Prostatic Neoplasms / genetics,  metabolism,  pathology
RNA Interference
Recombinant Fusion Proteins / metabolism
S-Phase Kinase-Associated Proteins / genetics,  metabolism*
Tetrazolium Salts / metabolism
Thiazolidinediones / pharmacology*
Ubiquitin-Protein Ligases / genetics,  metabolism*
beta Catenin / metabolism*
Grant Support
Reg. No./Substance:
0/Cell Cycle Proteins; 0/Cullin 1; 0/Cullin Proteins; 0/F-Box Proteins; 0/Formazans; 0/PPAR gamma; 0/Recombinant Fusion Proteins; 0/S-Phase Kinase-Associated Proteins; 0/Tetrazolium Salts; 0/Thiazolidinediones; 0/beta Catenin; 23305-68-2/MTT formazan; EC Transferase; EC Ligases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Functional characterization of the promoter of human carbonyl reductase 1 (CBR1). Role of XRE elemen...
Next Document:  A quantitative estimate of bare-metal stenting compared with balloon angioplasty in patients with ac...